Document text
Principal Investigator: Suzanne Devkota
Organization: CEDARS-SINAI MEDICAL CENTER
Fiscal Year: 2020
Award: $371,859
Funding agency: National Institute of Diabetes and Digestive and Kidney Diseases
Project Summary
The COVID-19 pandemic currently has infected over 4 million people worldwide and led to over 300,000 deaths.
These numbers continue to grow and with an anticipated resurgence in the fall and winter months. It is now clear
that SARS-CoV-2 can enter the gastrointestinal (GI) tract, that it can bind to the ACE2 receptor abundantly
expressed on intestinal epithelial cells, that it can be isolated live from stool, and that it sheds in the stool for
several weeks after COVID-19 symptom onset. This information combined with the observations that GI
manifestations of the disease, such as nausea and diarrhea, appear to be on the rise, place an urgent need for
more clearly understanding the intestinal microenvironment in patients with COVID-19. This broad objective will
not only allow for more tailored treatment for patients with GI manifestations currently diagnosed with COVID-
19, it will also help to understand whether a perturbed GI tract as a result of COVID-19 may lead to later GI
pathology. Perhaps most importantly, this objective will help understand the factors that influence degree of
SARS-CoV-2 GI persistence and shedding in stool, which directly relate to the potential of fecal-oral
transmission. This proposal specifically addresses these objectives by examining whether the extensive
antibiotics administered to COVID-19 patients are creating unintended effects on the GI tract that result in a
favorable environment for SARS-CoV-2 infection and persistence in the gut. The principle of competitive
exclusion has been demonstrated in the human GI tract in multiple publications using both oral and intravenous
antibiotics, whereby the suppression of the total bacterial community and/or specific members, can result in
increased colonization by fungi, viruses, and antibiotic-resistant bacteria. Among the many roles of the gut
microbiota, one fundamental role is to provide colonization resistance against foreign invaders. We do not yet
know how this microbial ecology plays out in the context of SARS-CoV-2. We hypothesize that antibiotic
perturbation of the gut microbiota and its metabolome in COVID-19 patients results in increased load and
persistence of SARS-CoV-2 in the intestines, and intestinal inflammation. We believe this may reflect disease
stage/severity. As a result, we anticipate findings will be rapidly translated to govern clinical management
of antimicrobials in patients as well as provide insight into pathways that influence transmission,
development and resolution of COVID-19. Using biobanked specimens from COVID-19 patients that we have
prospectively collected, we will test our hypotheses in the following specific aims: Aim 1. Determine the
relationship between bacterial and fungal intestinal communities and SARS-CoV-2 viral load longitudinally in
SARS-CoV-2 positive and negative patients, with and without exposure to different antibiotics, and Aim 2.
Determine whether alterations to the gut microbiome is reflected in an altered metabolite and inflammatory
profile.
Terms: <2019 novel coronavirus><2019-nCoV><Address><Alimentary Canal><Antibiotic Agents><Antibiotic Drugs><Antibiotics><Bacterial Antibiotic Resistance><Binding><Biological Markers><COVID-19><COVID-19 epidemic><COVID-19 pandemic><COVID19><COVID19 epidemic><COVID19 pandemic><Cessation of life><Clinical Management><Communities><Death><Development><Diagnosis><Diarrhea><Digestive Tract><Disease><Disorder><Ecology><Environment><Environmental Science><Epithelial Cells><Exclusion><Exposure to><Feces><GI Tract><GI microbiome><GI microbiota><Gastrointestinal Tract><Gastrointestinal microbiota><Gastrointestinal tract structure><Human><Infection><Inflammatory><Intestinal><Intestines><Intravenous><Lead><Miscellaneous Antibiotic><Modern Man><Molecular Interaction><Nausea><Oral><Pathology><Pathway interactions><Patients><Pb element><Play><Publications><Receptor Protein><Research Specimen><Resolution><Role><SARS-CoV-2><SARS-CoV2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related coronavirus 2><Scientific Publication><Severe acute respiratory syndrome coronavirus 2><Severities><Site><Specimen><Symptoms><Testing><Translating><Transmission><Viral><Viral Burden><Viral Load><Viral Load result><Virus><Wuhan coronavirus><alimentary tract><anti-microbial><antibiotic resistant bacteria><antimicrobial><bacterial antibiotic resistant><bacterial community><bacterial resistance to antibiotic><bio-markers><biobank><biologic marker><biomarker><biorepository><bowel><colonization resistance><corona virus disease 2019><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><coronavirus disease 2019><coronavirus disease 2019 epidemic><coronavirus disease 2019 pandemic><customized therapy><customized treatment><developmental><digestive canal><digestive tract microbiome><enteric microbial community><enteric microbiome><enteric microbiota><falls><fungus><gastrointestinal><gastrointestinal microbial flora><gastrointestinal microbiome><gut commensal><gut community><gut flora><gut inflammation><gut microbe community><gut microbial community><gut microbial composition><gut microbial consortia><gut microbiome><gut microbiota><gut microbiotic><gut microflora><gut-associated microbiome><heavy metal Pb><heavy metal lead><individualized medicine><individualized patient treatment><individualized therapy><individualized treatment><inflammatory disease of the intestine><inflammatory disorder of the intestine><insight><intestinal autoinflammation><intestinal biome><intestinal epithelium><intestinal flora><intestinal inflammation><intestinal microbes><intestinal microbiome><intestinal microbiota><intestinal microflora><intestinal tract microflora><member><metabolism measurement><metabolome><metabolomics><metabonome><metabonomics><microbial><pathway><patient specific therapies><patient specific treatment><prospective><public health emergency><receptor><social role><stool><tailored medical treatment><tailored therapy><tailored treatment><transmission process><unique treatment>